MicroRNAs in Cancer Treatment-Induced Cardiotoxicity
Cancer treatment has made significant progress in the cure of different types of tumors. Nevertheless, its clinical use is limited by unwanted cardiotoxicity. Aside from the conventional chemotherapy approaches, even the most newly developed, i.e., molecularly targeted therapy and immunotherapy, exh...
Main Authors: | Laura Pellegrini, Sara Sileno, Marco D’Agostino, Eleonora Foglio, Maria Cristina Florio, Vincenzo Guzzanti, Matteo Antonio Russo, Federica Limana, Alessandra Magenta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/3/704 |
Similar Items
-
microRNAs involved in psoriasis and cardiovascular diseases
by: Sara Sileno, et al.
Published: (2021-07-01) -
Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity
by: Sonia Gioffré, et al.
Published: (2019-02-01) -
Advances of MicroRNA in the diagnosis and mechanism of doxorubicin-induced cardiotoxicity
by: Yi-Xin Su, et al.
Published: (2021-01-01) -
microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
by: Jéssica Diniz Pereira, et al.
Published: (2020-11-01) -
MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats
by: Shu-Rong Wang, et al.
Published: (2019-03-01)